InMed Pharmaceuticals Inc. financial data

Symbol
INM on Nasdaq
Location
Vancouver, British Columbia, Canada
Fiscal year end
30 June
Latest financial report
10-Q - Q4 2025 - 11 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 579% %
Quick Ratio 54% %
Debt-to-equity 19% %
Return On Equity -74% % 19%
Return On Assets -62% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,919,186 shares 142%
Common Stock, Shares, Outstanding 2,804,186 shares 287%
Entity Public Float $3,316,582 USD 41%
Common Stock, Value, Issued $92,046,396 USD 8.9%
Weighted Average Number of Shares Outstanding, Basic 3,954,549 shares 460%
Weighted Average Number of Shares Outstanding, Diluted 3,954,549 shares 460%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $4,506,597 USD -6.7%
Cost of Revenue $3,166,965 USD 1.4%
Research and Development Expense $2,470,847 USD -15%
General and Administrative Expense $6,499,197 USD 2.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $7,664,363 USD 3.1%
Net Income (Loss) Attributable to Parent $7,664,363 USD 3.1%
Earnings Per Share, Basic -2.96 USD/shares 61%
Earnings Per Share, Diluted -2.96 USD/shares 61%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,954,834 USD 103%
Cash, Cash Equivalents, and Short-term Investments $7,000,000 USD 100%
Accounts Receivable, after Allowance for Credit Loss, Current $182,967 USD -30%
Inventory, Net $947,898 USD -14%
Assets, Current $8,788,654 USD 61%
Property, Plant and Equipment, Net $764,254 USD -38%
Intangible Assets, Net (Excluding Goodwill) $1,538,576 USD -9.6%
Other Assets, Noncurrent $100,000 USD 0%
Assets $11,191,484 USD 32%
Accounts Payable, Current $2,000 USD
Employee-related Liabilities, Current $376,656 USD 12%
Accrued Liabilities, Current $85,521 USD
Liabilities, Current $1,479,993 USD -17%
Operating Lease, Liability, Noncurrent $123,827 USD -77%
Liabilities $1,603,820 USD -31%
Accumulated Other Comprehensive Income (Loss), Net of Tax $128,569 USD 0%
Retained Earnings (Accumulated Deficit) $120,993,014 USD -6.8%
Stockholders' Equity Attributable to Parent $9,587,664 USD 55%
Liabilities and Equity $11,191,484 USD 32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,607,616 USD 12%
Net Cash Provided by (Used in) Financing Activities $137,178 USD -116%
Common Stock, Shares, Issued 2,804,186 shares 287%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6,954,834 USD 103%
Deferred Tax Assets, Valuation Allowance $26,821,820 USD 18%
Deferred Tax Assets, Gross $26,821,820 USD 18%
Operating Lease, Liability $531,949 USD -44%
Depreciation $50,204 USD 5.2%
Lessee, Operating Lease, Liability, to be Paid $551,389 USD -46%
Property, Plant and Equipment, Gross $2,330,559 USD -11%
Operating Lease, Liability, Current $408,122 USD -2.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two $219,261 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $125,292 USD -73%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $19,440 USD -69%
Lessee, Operating Lease, Liability, to be Paid, Year Three $219,261 USD -80%
Deferred Tax Assets, Operating Loss Carryforwards $5,400,000 USD -28%
Amortization of Intangible Assets $162,636 USD -5.4%
Depreciation, Depletion and Amortization $53,202 USD -2.5%
Share-based Payment Arrangement, Expense $22,610 USD -85%